Position in GH
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$203,290
-$3,526 QoQ
Shares Held
1,355
-39.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#449
of 594 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $48,669,683 across 20 Diagnostics & Research names. GH ranks #19 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
27,658 | $13,866,614 | |
| 2 | DHR |
Danaher Corp /De/
|
30,005 | $5,715,352 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
22,836 | $4,412,371 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
7,511 | $3,954,090 | |
| 5 | NTRA |
Natera, Inc.
|
13,441 | $3,648,559 | |
| 6 | LH |
Labcorp Holdings Inc.
|
10,503 | $2,940,840 | |
| 7 | DGX |
Quest Diagnostics Inc
|
12,532 | $2,656,157 | |
| 8 | ILMN |
Illumina, Inc.
|
12,278 | $2,158,840 |
All Filings in GH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $203,290 | 1,355 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $206,816 | 2,239 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $240,743 | 2,357 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $238,298 | 3,814 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $208,784 | 4,012 | Shares | Sole | 2025-08-04 | |
| 2020-03-31 | $277,495 | 3,987 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||